• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑死亡器官捐献者伴中枢神经系统肿瘤的捐献安全性:韩国移植结局分析。

Safety of Donation From Brain-dead Organ Donors With Central Nervous System Tumors: Analysis of Transplantation Outcomes in Korea.

机构信息

Korea Organ Donation Agency, Seodaemun-gu, Seoul, Republic of Korea.

Department of Surgery and Transplantation Research Institute, Seoul National University College of Medicine, Jongno-gu, Seoul, Republic of Korea.

出版信息

Transplantation. 2020 Mar;104(3):460-466. doi: 10.1097/TP.0000000000002994.

DOI:10.1097/TP.0000000000002994
PMID:31596740
Abstract

BACKGROUND

This study aims to verify the condition of recipients of solid organs from donors with central nervous system (CNS) tumors and determine the risk of disease transmission due to transplantation.

METHODS

Twenty-eight brain-dead organ donors with CNS tumors and 91 recipients who received solid organs from January 1, 2005, to December 31, 2014 in Korea were investigated using the Korean Network of Organ Sharing data.

RESULTS

Of the 36 recipients of organs from the 11 donors whose pathological results were not verified, 4 developed the following tumors: renal cell carcinoma, carcinoma in situ of the cervix uteri, B-cell lymphoma, and colon cancer. Among 51 recipients from 17 donors with CNS tumor, no recipient had the same tumor as the donors. Six were classified as high-risk donors according to the World Health Organization classification, and 14 recipients from these donors did not develop tumor after transplantation. The remaining 11 donors were classified as low-risk donors according to the World Health Organization classification but as high-risk donors according to the Malignancy Subcommittee of the Disease Transmission Advisory Committee of the Organ Procurement and Transplantation Network/United Network for Organ Sharing. Of the 37 recipients, 3 had recurring hepatocellular carcinoma with lung and bone metastases, thyroid cancer, and Kaposi's sarcoma after transplantation.

CONCLUSIONS

The risk of disease transmission due to organ transplantation from donors with CNS tumors was very low. Thus, organ donation from such donors should be promoted actively to expand the donor range.

摘要

背景

本研究旨在验证来自中枢神经系统(CNS)肿瘤供者的实体器官受者的状况,并确定因移植而导致疾病传播的风险。

方法

使用韩国器官共享网络的数据,对 2005 年 1 月 1 日至 2014 年 12 月 31 日期间来自韩国的 28 例脑死亡器官供者和 91 例接受来自 CNS 肿瘤供者的实体器官的受者进行了调查。

结果

在未对 11 例供者的病理结果进行验证的 36 例器官受者中,有 4 例发生了以下肿瘤:肾细胞癌、子宫颈原位癌、B 细胞淋巴瘤和结肠癌。在 51 例来自 17 例 CNS 肿瘤供者的受者中,没有受者与供者患有相同的肿瘤。根据世界卫生组织分类,有 6 例被归类为高危供者,而这 6 例供者的 14 例受者在移植后未发生肿瘤。其余 11 例供者根据世界卫生组织分类被归类为低危供者,但根据器官采购与移植网络/联合器官共享网络疾病传播咨询委员会恶性肿瘤小组委员会的分类则被归类为高危供者。在 37 例受者中,有 3 例在移植后出现了复发性肝细胞癌伴肺和骨转移、甲状腺癌和卡波西肉瘤。

结论

来自 CNS 肿瘤供者的器官移植导致疾病传播的风险非常低。因此,应积极提倡此类供者的器官捐赠,以扩大供者范围。

相似文献

1
Safety of Donation From Brain-dead Organ Donors With Central Nervous System Tumors: Analysis of Transplantation Outcomes in Korea.脑死亡器官捐献者伴中枢神经系统肿瘤的捐献安全性:韩国移植结局分析。
Transplantation. 2020 Mar;104(3):460-466. doi: 10.1097/TP.0000000000002994.
2
Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-A UNOS database study.来自患有中枢神经系统肿瘤的成年供体的胸部同种异体移植术后肿瘤传播风险——一项器官共享联合网络(UNOS)数据库研究
Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12919. Epub 2017 Mar 2.
3
Transmission and Non-transmission of Melanoma From Deceased Solid Organ Donors to Transplant Recipients: Risks and Missed Opportunities.从已故实体器官供体向移植受者传播和不传播黑色素瘤:风险和错失的机会。
Transplantation. 2024 Jul 1;108(7):1623-1631. doi: 10.1097/TP.0000000000004961. Epub 2024 Feb 29.
4
Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry.全国移植登记处器官捐献者向移植受者传播癌症的风险估计。
Br J Surg. 2014 Jun;101(7):768-74. doi: 10.1002/bjs.9460. Epub 2014 Apr 28.
5
Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.供体中的中枢神经系统肿瘤:误诊会带来高发病率和死亡率。
Transplant Proc. 2005 Mar;37(2):583-4. doi: 10.1016/j.transproceed.2004.12.125.
6
Rapid screening for safety of donation from donors with central nervous system malignancies.对患有中枢神经系统恶性肿瘤的捐赠者进行捐赠安全性快速筛查。
Medicine (Baltimore). 2020 Dec 4;99(49):e22808. doi: 10.1097/MD.0000000000022808.
7
Cancer transmission from organ donors-unavoidable but low risk.器官捐献者传播癌症:不可避免但风险低。
Transplantation. 2012 Dec 27;94(12):1200-7. doi: 10.1097/TP.0b013e318272df41.
8
First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.器官共享联合网络移植肿瘤登记处的首份报告:有癌症病史的捐赠者。
Transplantation. 2000 Dec 27;70(12):1747-51. doi: 10.1097/00007890-200012270-00014.
9
Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.移植导致肿瘤及其他疾病传播的风险:一项基于人群的器官捐献者未被识别的恶性肿瘤及其他疾病研究。
Transplantation. 2002 Nov 27;74(10):1409-13. doi: 10.1097/00007890-200211270-00012.
10
Transplant tumor registry: donors with central nervous system tumors1.移植肿瘤登记处:患有中枢神经系统肿瘤的供体1。
Transplantation. 2002 Feb 27;73(4):579-82. doi: 10.1097/00007890-200202270-00017.

引用本文的文献

1
Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?有既往恶性肿瘤病史的供体:何时进行器官移植才安全?
Transpl Int. 2025 Jan 24;38:13716. doi: 10.3389/ti.2025.13716. eCollection 2025.
2
Risk factors of extraneural spreading in astrocytomas and oligodendrogliomas in donors with gliomas: A systematic review.胶质瘤供体中星形细胞瘤和少突胶质细胞瘤神经外扩散的危险因素:一项系统综述。
World J Transplant. 2022 Jun 18;12(6):131-141. doi: 10.5500/wjt.v12.i6.131.